INCY
Incyte Corporation
NASDAQ: INCY · HEALTHCARE · BIOTECHNOLOGY
$100.32
+1.13% today
Updated 2026-06-05
Market cap
$21.68B
P/E ratio
15.33
P/S ratio
4.04x
EPS (TTM)
$7.08
Dividend yield
—
52W range
$67 – $112
Volume
1.4M
WallStSmart proprietary scores
80
out of 100
Grade: A
Strong Buy
Investment rating
8.7
Growth
A9.0
Quality
A+9.5
Profitability
A+9.3
Valuation
A+5/9
Piotroski F-Score
Moderate
3.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$102.00
+1.67%
12-Month target
$91.03
-9.26%
Intrinsic (DCF)
$593.92
Margin of safety
+83.36%
2 Strong Buy9 Buy15 Hold1 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.89 — safe zone
+ Profit margin 26.70% — above average
+ ROE 25.79% — strong efficiency
+ Free cash flow $359.15M — positive
+ Revenue growth 20.90% QoQ
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $3.39B | $3.70B | $4.24B | $5.14B | $5.36B | $5.7B |
| Net income | $340.66M | $597.60M | $32.62M | $1.29B | $303.33M | — |
| EPS | — | — | — | — | $7.08 | $7.66 |
| Free cash flow | $892.11M | $449.00M | $249.07M | $1.35B | $359.15M | — |
| Profit margin | 10.04% | 16.17% | 0.77% | 25.03% | 26.70% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | CAGNONI, PABLO J | Sale | 25,469 | $95.59 |
| 2026-05-26 | TRAY, THOMAS | Sale | 2,051 | $97.35 |
| 2026-05-26 | BIENAIME, JEAN JACQUES | Sale | 15,000 | — |
Peer comparison
Smart narrative
Incyte Corporation trades at $100.32. representing a P/E of 15.33x trailing earnings. Our Smart Value Score of 80/100 indicates the stock is excellent. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 3.89, it sits in the safe zone. TTM revenue stands at $5.36B. with profit margins at 26.70%. Our DCF model estimates intrinsic value at $593.92.
Frequently asked questions
What is Incyte Corporation's stock price?
Incyte Corporation (INCY) trades at $100.32, on a P/E of 15.3x and a P/S of 4.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Incyte Corporation overvalued?
Incyte Corporation carries a Smart Value Score of 80/100 (Grade A), which we rate Strong Buy. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $593.92 versus the $100.32 price, a 83.4% margin of safety on a cash flow basis.
What is the price target of Incyte Corporation (INCY)?
The 12-month analyst consensus target is $102.00, about 1.7% above the current $100.32. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Incyte Corporation (INCY)?
Our DCF model estimates intrinsic value at $593.92, a +83.4% margin of safety versus today's $100.32. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Incyte Corporation's revenue?
Incyte Corporation's trailing twelve-month revenue is $5.36B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Incyte Corporation's Altman Z-Score is 3.89, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.04x
ROE25.79%
Beta0.79
50D MA$97.80
200D MA$96.50
Shares out0.20B
Float0.17B
Short ratio—
Avg volume1.4M
Performance
1 week+0.00%
1 month+7.42%
3 months+10.09%
YTD+3.65%
1 year—
3 years—
5 years—